Weight Loss

Weight Loss News

  • Gabriel Garcia Marquez, Leonard M. Rosen: Obituaries This Week

    This week’s notable deaths included a Nobel Prize-winning novelist; a co-founder of Wachtell, Lipton, Rosen & Katz law firm who helped avert a New York City bankruptcy in 1975; and the billionaire founder of France’s second-largest drugmaker who was the focus of a healthcare scandal. Below are summaries of these and other obituaries from the past week.

  • Jacques Servier, Focus of French Health Scandal, Dies at 92

    Jacques Servier, the billionaire founder of France’s second-largest drugmaker, Les Laboratoires Servier, who late in life faced accusations of hiding information about life-threatening risks caused by a diabetes drug his companies sold, has died. He was 92.

  • Manipulate Me: The Booming Business in Behavioral Finance

    It's hard to find a place today where concepts of behavioral finance aren’t being applied to real-world situations. From London to Washington to Sydney, governments are experimenting with the psychology of decision-making and trying to “nudge” citizens toward better behaviors, whether that means saving more for retirement or signing an organ donation card. Meanwhile, businesses see opportunities for higher profits. To grab more attention and dollars from consumers, companies as far afield as banks and fitness-app makers carefully design their offerings with consumers’ decision-making quirks in mind.

  • Weight-Loss Surgery Stymies Diabetes Better Than Drugs

    Weight-loss surgery may be a better way to treat diabetes than traditional drug therapy alone, according to a study that found the operation was more likely to keep the chronic condition at bay for at least three years.

  • Glaxo Recalls Weight-Loss Drug Alli on Tampering Concern

    GlaxoSmithKline Plc is recalling its weight-loss drug Alli in the U.S. and Puerto Rico after receiving complaints from consumers in seven states.

  • Herbalife Strengthens Ties With Icahn as Ackman War Rages

    Herbalife Ltd.’s feud with hedge- fund manager Bill Ackman has driven the company further into the arms of another billionaire investor: Carl Icahn.

  • U.S. Stocks Drop After Factory Data as Biotech Share Fall

    U.S. stocks fell for a second day as economic data signaled a slowdown in American manufacturing and some banks said Russia’s economy will enter a recession.

  • Ackman’s Pershing Near Break Even on Losing Herbalife Bet

    Bill Ackman is close to breaking even on his wager against Herbalife Ltd., a trade by his Pershing Square Capital Management LP that he last month called its biggest loser, after the stock plunged following disclosure of a U.S. Federal Trade Commission investigation.

  • Herbalife Reschedules Investor Meeting for Talks With Icahn

    Herbalife Ltd., the nutrition and weight-loss company that’s being investigated by the Federal Trade Commission, will delay its shareholder meeting by five days next month to give it more time for discussions with activist investor Carl Icahn.

  • Ackman Investigation Finds Herbalife Violates China Laws

    Billionaire Bill Ackman, renewing his attack on the nutrition and weight-loss company Herbalife Ltd., said its investigation into the business’s Chinese operations found that they violate direct-selling laws.

Sponsored Links
Curation software by Lingospot